161 related articles for article (PubMed ID: 11487281)
21. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
[TBL] [Abstract][Full Text] [Related]
23. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
[TBL] [Abstract][Full Text] [Related]
24. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
[TBL] [Abstract][Full Text] [Related]
25. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
26. Identification of the antigen recognized by the monoclonal antibody 31D8.
Spiekermann K; Roesler J; Elsner J; Lohmann-Matthes ML; Welte K; Malech H; Gallin JI; Emmendoerffer A
Exp Hematol; 1996 Feb; 24(3):453-8. PubMed ID: 8599975
[TBL] [Abstract][Full Text] [Related]
27. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte-macrophage-colony-stimulating factor differentially regulates neutrophil migration across IL-1-activated and nonactivated human endothelium.
Yong KL; Linch DC
J Immunol; 1993 Mar; 150(6):2449-56. PubMed ID: 7680693
[TBL] [Abstract][Full Text] [Related]
29. The effect of cytokines on human neutrophil Fc receptor-mediated phagocytosis.
Capsoni F; Bonara P; Minonzio F; Ongari AM; Colombo G; Rizzardi GP; Zanussi C
J Clin Lab Immunol; 1991 Mar; 34(3):115-24. PubMed ID: 1667943
[TBL] [Abstract][Full Text] [Related]
30. Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors.
Lopez AF; Nicola NA; Burgess AW; Metcalf D; Battye FL; Sewell WA; Vadas M
J Immunol; 1983 Dec; 131(6):2983-8. PubMed ID: 6605995
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-macrophage colony-stimulating factor enhances EBV-induced synthesis of chemotactic factors in human neutrophils.
Roberge CJ; McColl SR; Larochelle B; Gosselin J
J Immunol; 1998 Mar; 160(5):2442-8. PubMed ID: 9498788
[TBL] [Abstract][Full Text] [Related]
32. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the cytolytic trigger molecules G7/PNK-E as a molecular complex on the surface of porcine phagocytes.
Aller SC; Cho D; Kim YB
Cell Immunol; 1995 Apr; 161(2):270-8. PubMed ID: 7697738
[TBL] [Abstract][Full Text] [Related]
34. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
[TBL] [Abstract][Full Text] [Related]
35. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
[TBL] [Abstract][Full Text] [Related]
36. Biosynthetic granulocyte-macrophage colony-stimulating factor enhances neutrophil cytotoxicity toward human leukemia cells.
Fabian I; Baldwin GC; Golde DW
Leukemia; 1987 Aug; 1(8):613-7. PubMed ID: 3312847
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
Young DA; Lowe LD; Clark SC
J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
[TBL] [Abstract][Full Text] [Related]
38. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
39. The effect of IFN-gamma and colony-stimulating factors on the expression of neutrophil cell membrane receptors.
Buckle AM; Hogg N
J Immunol; 1989 Oct; 143(7):2295-301. PubMed ID: 2476506
[TBL] [Abstract][Full Text] [Related]
40. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
Braster R; O'Toole T; van Egmond M
Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
